Clinical outcomes of Japanese MPO-ANCA-related nephritis: Significance of initial renal death for survival

Internal Medicine

Volumn 51, Issue 15, 2012, Pages 1969-1976

  Watanabe, Kimio ^a   Tani, Yoshihiro ^a   Kimura, Hiroshi ^b   Tanaka, Kenichi ^a   Hayashi, Yoshimitsu ^a   Asahi, Koichi ^a   Sato, Keiji ^a   Sato, Mamoru ^c   Matsushima, Masato ^d   Nakayama, Masaaki ^a   Watanabe, Tsuyoshi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b Fujita General Hospital   (Japan)

^c Ohta General Hospital   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti myeloperoxidase anti neutrophil cytoplasmic antibody (MPO ANCA) related nephritis; Japanese; Microscopic polyangitis (MPA); Rapidly progressive glomerulonephritis (rpgn); The birmingham vasculitis activity score (BVAS)

Indexed keywords

CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYELOPEROXIDASE; PREDNISOLONE;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; BIRMINGHAM VASCULITIS ACTIVITY SCORE; DEATH; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; INCIDENCE; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; PROGNOSIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE;

AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; PEROXIDASE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84864498819     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7727     Document Type: Article

References (23)

1. Koyama A, Yamagata K, Makino H, et al. A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clinical and Experimental Nephrology 13: 633-650, 2009.
2. Guidelines for the treatment of rapidly progressive glomerulonephritis, second version. The Japanese Journal of Nephrology 53: 509-555, 2011 (in Japanese).
3. Corral-Gudino L, Borao-Cengotita-Bengoa M, Del Pino-Montes J, Lerma-Marquez JL. Overall survival, renal survival and relapse in patients with microscopic polyangiitis: a systematic review of current evidence. Rheumatology (Oxford) 50: 1414-1423, 2011.
4. Mukhtyar C, Flossmann O, Hellmich B, et al. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis 67: 1004-1010, 2008.
5. Phillip R, Luqmani R. Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol 26: S94-S104, 2008.
6. Flossmann O, Berden A, de Groot K, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70: 488-494, 2011.
7. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. Journal of the American Society of Nephrology: JASN 7: 23-32, 1996.
8. Fujimoto S, Watts RA, Kobayashi S, et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology (Oxford) 50: 1916-1920, 2011.
9. Harper L, Savage CO. ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients. Rheumatology (Oxford) 44: 495-501, 2005.
10. Luqmani RA, Bacon PA, Moots RJ, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 87: 671-678, 1994.
11. Mukhtyar C, Lee R, Brown D, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68: 1827-1832, 2009.
12. Itabashi M, Takei T, Yabuki Y, et al. Clinical outcome and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan. Nephron Clin Pract 115: c21-c27, 2010.
13. Ahn JK, Hwang JW, Lee J, Jeon CH, Cha HS, Koh EM. Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea. Rheumatol Int 2011 [Epub ahead of print].
14. Itabashi M, Takei T, Morito T, et al. Estimation of BVAS in patients with microscopic polyangiitis in Japan. Clin Rheumatol 30: 1499-1505, 2011.
15. Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classification of the ANCAassociated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66: 222-227, 2007.
16. Kaplan-Pavlovcic S, Cerk K, Kveder R, et al. Clinical prognostic factors of renal outcome in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis in elderly patients. Nephrol Dial Transplant 18 (5 Suppl): v5-v7, 2003.
17. Chen M, Yu F, Zhang Y, Zhao MH. Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients. Medicine (Baltimore) 87: 203-209, 2008.
18. Slot MC, Tervaert JW, Franssen CF, et al. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int 63: 670-677, 2003.
19. Lane SE, Watts RA, Shepstone L, et al. Primary systemic vasculitis: clinical features and mortality. QJM 98: 97-111, 2005.
20. Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. The New England Journal of Medicine 349: 36-44, 2003.
21. Booth AD, Almond MK, Burns A, et al. Outcome of ANCAassociated renal vasculitis: a 5-year retrospective study. American journal of kidney diseases: the official journal of the National Kidney Foundation 41: 776-784, 2003.
22. Gayraud M, Guillevin L, le Toumelin P, et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 44: 666-675, 2001.
23. Bomback AS, Appel GB, Radhakrishnan J, et al. ANCAassociated glomerulonephritis in the very elderly. Kidney Int 79: 757-764, 2011.